249 related articles for article (PubMed ID: 19075979)
1. Therapeutic applications of antisense oligonucleotides in asthma and allergy.
Isidoro-García M; Dávila I
Recent Pat Inflamm Allergy Drug Discov; 2007 Nov; 1(3):171-5. PubMed ID: 19075979
[TBL] [Abstract][Full Text] [Related]
2. Antisense oligonucleotides.
Kashihara N; Maeshima Y; Makino H
Exp Nephrol; 1998; 6(1):84-8. PubMed ID: 9523178
[TBL] [Abstract][Full Text] [Related]
3. Antisense- and RNA interference-based therapeutic strategies in allergy.
Popescu FD
J Cell Mol Med; 2005; 9(4):840-53. PubMed ID: 16364194
[TBL] [Abstract][Full Text] [Related]
4. Antisense Oligonucleotide-Based Therapy for Neuromuscular Disease.
Sardone V; Zhou H; Muntoni F; Ferlini A; Falzarano MS
Molecules; 2017 Apr; 22(4):. PubMed ID: 28379182
[TBL] [Abstract][Full Text] [Related]
5. Making sense of antisense.
Murakami A
Trends Mol Med; 2001 Oct; 7(10):430-1. PubMed ID: 11597507
[No Abstract] [Full Text] [Related]
6. Sense and antisense: therapeutic potential of oligonucleotides and interference RNA in asthma and allergic disorders.
Ball HA; Van Scott MR; Robinson CB
Clin Rev Allergy Immunol; 2004 Dec; 27(3):207-17. PubMed ID: 15630157
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA regulation of allergic inflammation and asthma.
Pua HH; Ansel KM
Curr Opin Immunol; 2015 Oct; 36():101-8. PubMed ID: 26253882
[TBL] [Abstract][Full Text] [Related]
8. Antisense oligonucleotides in cutaneous therapy.
Wraight CJ; White PJ
Pharmacol Ther; 2001 Apr; 90(1):89-104. PubMed ID: 11448727
[TBL] [Abstract][Full Text] [Related]
9. Antisense technology: an emerging platform for cardiovascular disease therapeutics.
Lee RG; Crosby J; Baker BF; Graham MJ; Crooke RM
J Cardiovasc Transl Res; 2013 Dec; 6(6):969-80. PubMed ID: 23856914
[TBL] [Abstract][Full Text] [Related]
10. Application of antisense technology to therapeutics.
Heidenreich O; Kang SH; Xu X; Nerenberg M
Mol Med Today; 1995 Jun; 1(3):128-33. PubMed ID: 9415148
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic antisense and ribozymes.
Rossi JJ
Br Med Bull; 1995 Jan; 51(1):217-25. PubMed ID: 7767645
[TBL] [Abstract][Full Text] [Related]
12. Neutrally charged phosphorodiamidate morpholino antisense oligomers: uptake, efficacy and pharmacokinetics.
Arora V; Devi GR; Iversen PL
Curr Pharm Biotechnol; 2004 Oct; 5(5):431-9. PubMed ID: 15544491
[TBL] [Abstract][Full Text] [Related]
13. RASONs: a novel antisense oligonucleotide therapeutic approach for asthma.
Sandrasagra A; Tang L; Leonard SA; Teng K; Li Y; Mannion JC; Nyce JW
Expert Opin Biol Ther; 2001 Nov; 1(6):979-83. PubMed ID: 11728229
[TBL] [Abstract][Full Text] [Related]
14. Respirable antisense oligonucleotides: a new, third drug class targeting respiratory disease.
Nyce J
Curr Opin Allergy Clin Immunol; 2002 Dec; 2(6):533-6. PubMed ID: 14752337
[TBL] [Abstract][Full Text] [Related]
15. Antisense therapy against CCR3 and the common beta chain attenuates allergen-induced eosinophilic responses.
Gauvreau GM; Boulet LP; Cockcroft DW; Baatjes A; Cote J; Deschesnes F; Davis B; Strinich T; Howie K; Duong M; Watson RM; Renzi PM; O'Byrne PM
Am J Respir Crit Care Med; 2008 May; 177(9):952-8. PubMed ID: 18244953
[TBL] [Abstract][Full Text] [Related]
16. Antisense oligonucleotides as therapeutic agents.
Alama A; Barbieri F; Cagnoli M; Schettini G
Pharmacol Res; 1997 Sep; 36(3):171-8. PubMed ID: 9367660
[TBL] [Abstract][Full Text] [Related]
17. Antisense oligonucleotides: the state of the art.
Aboul-Fadl T
Curr Med Chem; 2005; 12(19):2193-214. PubMed ID: 16178780
[TBL] [Abstract][Full Text] [Related]
18. Antisense inhibition and adeno-associated viral vector delivery for reducing hypertension.
Phillips MI
Hypertension; 1997 Jan; 29(1 Pt 2):177-87. PubMed ID: 9039099
[TBL] [Abstract][Full Text] [Related]
19. [The application of antisense technology in ophthalmology].
Guo Y; Ge J
Yan Ke Xue Bao; 1998 Jun; 14(2):108-15. PubMed ID: 12580046
[TBL] [Abstract][Full Text] [Related]
20. Facilitating oligonucleotide delivery: helping antisense deliver on its promise.
Gewirtz AM; Stein CA; Glazer PM
Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3161-3. PubMed ID: 8622906
[No Abstract] [Full Text] [Related]
[Next] [New Search]
